Vice President of Finance, Principal Accounting Officer and Controller
Glenn Whaley is the Vice President of Finance, Principal Accounting Officer and Controller of the Company since May 2018. Previously he was Vice President of Finance, Interim Principal Accounting Officer and Controller from November 2017 to May 2018. Mr. Whaley joined Pernix Therapeutics as the Vice President of Financial Planning and Analysis in March 2015 and has more than 25 years of experience in Accounting and Finance roles.
Prior to joining Pernix, Mr. Whaley was Vice President Finance for Alvogen, Inc, a Global Pharmaceutical Company from May 2011 until March 2015. His responsibilities included Vice President Finance of US Operations from August 2013 to March 2015 and Global Corporate Controller from May 2011 to August 2013. Prior to Alvogen, Mr. Whaley served as Corporate Controller for ImClone Systems, a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology, from January 2007 to May 2011 and Senior Director of Financial Reporting from January 2005 to December 2006. Prior to ImClone Systems, Mr. Whaley served in financial roles of increasing levels of responsibility in the public accounting, pharmaceutical, and telecommunications industries.
Mr. Whaley holds a Bachelor of Science degree from Rutgers University Business School and is a Member of the New Jersey Society of Certified Public Accountants and the American Institute of Certified Public Accountants.